Volume 9, Issue 1 (6-2023)
Caspian J Reprod Med 2023, 9(1): 1-7 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zafardoust S, Sadeghi M R, Fatemi F, Jouhari S, Shahbakhsh A, Mohammad Akbari A, et al . Evaluating the efficacy of granulocyte-macrophage colony-stimulating factor in improving implantation rates in frozen embryo transfer cycles: a blind randomized-controlled study. Caspian J Reprod Med 2023; 9 (1) :1-7
URL: http://caspjrm.ir/article-1-224-en.html
URL: http://caspjrm.ir/article-1-224-en.html
Simin Zafardoust 
, Mohammad Reza Sadeghi * , Farnaz Fatemi , Sheyda Jouhari , Afsaneh Shahbakhsh , Azam Mohammad Akbari , Zohre Fathi , Zahra Sehat , Narges Maleki
, Mohammad Reza Sadeghi * , Farnaz Fatemi , Sheyda Jouhari , Afsaneh Shahbakhsh , Azam Mohammad Akbari , Zohre Fathi , Zahra Sehat , Narges Maleki
Abstract: (1861 Views)
Background: Implantation failure in assisted reproductive technologies (ART) remains a challenge. Granulocyte-macrophage colony-stimulating factor (GM-CSF) may enhance embryo implantation, but its efficacy needs more investigation. This study aimed to assess if adding GM-CSF to thawed embryo culture could improve implantation rates in frozen embryo transfer cycles.
Methods: One hundred rats were randomly assigned to GM-CSF or control groups at Avicenna Infertility Clinic, Tehran. Control group had standard embryo culture; GM-CSF group had embryos cultured in Embryogen® with GM-CSF. Pregnancy outcomes were assessed via serum β-HCG levels post frozen embryo transfer (FET) and ultrasonography at gestational week seven.
Results: No significant difference in blastocyst formation rates was found between groups. Positive beta-HCG levels were 36% in control and 40% in GM-CSF groups. Gestational sacs were detected in 36% of control and 34% of GM-CSF group during weeks 5-6. Clinical pregnancy rates were 32% in control and 30% in GM-CSF groups.
Conclusion: GM-CSF in embryo culture of thawed embryos shows no significant impact on blastocyst formation or pregnancy outcomes. However, interventions like these may enhance fertility treatments, warranting larger-scale clinical trials for further exploration.
Methods: One hundred rats were randomly assigned to GM-CSF or control groups at Avicenna Infertility Clinic, Tehran. Control group had standard embryo culture; GM-CSF group had embryos cultured in Embryogen® with GM-CSF. Pregnancy outcomes were assessed via serum β-HCG levels post frozen embryo transfer (FET) and ultrasonography at gestational week seven.
Results: No significant difference in blastocyst formation rates was found between groups. Positive beta-HCG levels were 36% in control and 40% in GM-CSF groups. Gestational sacs were detected in 36% of control and 34% of GM-CSF group during weeks 5-6. Clinical pregnancy rates were 32% in control and 30% in GM-CSF groups.
Conclusion: GM-CSF in embryo culture of thawed embryos shows no significant impact on blastocyst formation or pregnancy outcomes. However, interventions like these may enhance fertility treatments, warranting larger-scale clinical trials for further exploration.
Keywords: Assisted Reproductive Technologies (ART), Frozen embryo transfer (FET), Granulocyte-macrophage colony-stimulating factor (GM-CSF), Implantation rates, Clinical pregnancy
Type of Study: Original Research |
Subject:
Embryology
Received: 2023/04/17 | Accepted: 2023/06/10 | Published: 2023/06/28
Received: 2023/04/17 | Accepted: 2023/06/10 | Published: 2023/06/28
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
